GlycoErase™ HEK293T SLC35A2 Knockout Cell Line (CAT#: GLJF-0425-JF463)

Description	We are pleased to present an SLC35A2 knockout HEK293T cell line, designed to facilitate research on nucleoside-sugar transport. This cell line lacks the SLC35A2-encoded solute carrier family 35 member A2, a protein involved in nucleoside-sugar transport. Researchers can utilize this model to investigate the specific roles of SLC35A2 in glycan biosynthesis and its impact on cellular functions.
Product Type	KO Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:2~1:4
Cell Line	HEK293T
Lineage	Embryonic kidney

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Culture Medium	DMEM & FBS & Penicillin/Streptomycin
Application	Functional assay
Size	2 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	SLC35A2
Full Name	Solute carrier family 35 member A2
Alternative Name	UGT, UDP-Gal-Tr, UGT1, UGAT, UGT2, UGTL, UGALT
Location	Xp11.23
Gene ID	7355
Summary	Transports UDP-galactose from the cytosol into Golgi vesicles for glycan synthesis; mutations cause congenital disorder of glycosylation type IIm (CDG2M).